Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine

100% efficacy against severe Covid-19 disease and hospitalizations

Philips on track with its ESG commitments

Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems

Omicron sublineage BA.2 a Variant of Concern: WHO

As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern

ACUITE upgrades ratings of Bal Pharma

The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.

Sanofi India posts CY2021 PAT at Rs. 944.4 Cr

The company has reported total income of Rs.3031 crores during the calendar year ended December 31, 2021.

Prestige BioPharma’s facility receives EU-GMP certification

The facility will manufacture its Herceptin biosimilar, Tuznue

Biosion appoints Joel Edwards as Chief Business Officer

Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.

PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery

He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,

Daewoong Pharmaceutical posts strong financials in 2021

Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.

Prestige BioPharma’s Tuznue receives EU-GMP certification